Objective
The Innovac project comprises seven partners of whom two are SMEs. Due to the number of SMEs the project will be coordinated by an academic partner. SMEs will have rights of first refusal to the commercial exploitation of the work they participate in.
The consortium will develop three platform technologies that will be used for novel and highly innovative methods for vaccination against two of the most important poverty related diseases, TB and Malaria. An important aspect to this proposal is inclusion of a vaccine-producing SME from a developing country.
The three platforms are
1) Bacterial spores. Robust and heat-stable bioparticles with proven efficacy as mucosal vaccines,
2) Intracellular & Invasive bacteria including E. coli strains and Mycobacterium bovis (rBCG),
3) S-layer protein conjugates and S-layer protein coated liposomes, Innovac will focus on discovery activities including proof of principle studies to show Ag expression, testing of vaccines in vitro as well as challenge experiments in vivo.
The project will test and evaluate highly novel strategies for vaccination using recombinant systems, some in their infancy while others more developed.
This project will include construction of vaccine vehicles, their evaluation in animal models, challenge experiments and finally safety tests where appropriate to take potential vaccines to the stage of clinical evaluation. Inclusion of a commercial enterprise from a developing platform will enable technology transfer to that partner as well as resources to the European partners.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences infectious diseases malaria
- natural sciences biological sciences microbiology bacteriology
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2005-LIFESCIHEALTH-7
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
EGHAM
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.